Anti-Alpha-Synuclein Antibody (3H9)
Our Anti-Alpha-synuclein mouse monoclonal primary antibody detects bovine, chicken, horse, human, mouse, other mammals (predicted), pig, and rat Alpha-synuclein, and is IgG. It is validated for use in ICC, WB.
![Mixed neuron-glial cultures stained with Mouse monoclonal antibody to alpha Synuclein [3H9] M-1402-100 (red) and Chicken polylclonal antibody to MAP2 C-1382-50 (green). The alpha Synuclein antibody stains vesicular structures the perikarya and processes of the neurons in this image.](http://www.antibodiesinc.com/cdn/shop/files/m-1402-100-ihc_120x120.jpg?v=1759273227)
![Western Blot image with Mouse monoclonal antibody to alpha Synuclein [3H9] M-1402-100 on recombinant alpha-synuclein (left lane) and crude extract of mouse brain (right lane). Image courtesy Rogan Tinsley, Howard Florey Institute, University of Melbourne).](http://www.antibodiesinc.com/cdn/shop/files/m-1402-100-wb_120x120.jpg?v=1759273227)
Mixed neuron-glial cultures stained with Mouse monoclonal antibody to alpha Synuclein [3H9] M-1402-100 (red) and Chicken polylclonal antibody to MAP2 C-1382-50 (green). The alpha Synuclein antibody stains vesicular structures the perikarya and processes of the neurons in this image.
Click on image to zoom
SKU: M-1402-100
Product Details
Alpha-synuclein
Alpha synuclein is an abundant 140 amino acid neuronal protein, expressed primarily at presynaptic terminals in the central nervous system. FUNCTION: May be involved in the regulation of dopamine release and transport. Soluble protein, normally localized primarily at the presynaptic region of axons, which can form filamentous aggregates that are the major non amyloid component of intracellular inclusions in several neurodegenerative diseases (synucleinopathies). Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase 3 activation. TISSUE SPECIFICITY: Expressed principally in brain but is also expressed in low concentrations in all tissues examined except in liver. Concentrated in presynaptic nerve terminals.SUBUNIT: Soluble monomer which can form filamentous aggregates. Interacts with UCHL1. Interacts with phospholipase D and histones. SUBCELLULAR LOCATION: Cytoplasm. Membrane. Nucleus. Note=Membrane-bound in dopaminergic neurons. Also found in the nucleus. ALTERNATIVE PRODUCTS: 3 named isoforms produced by alternative splicing. Additional isoforms seem to exist.
IgG
Monoclonal
3H9
IgG1
ICC, WB
Mouse
14-15 kDa
Recombinant full length human alpha synuclein expressed and purified from E. coli
Human
Bovine, Chicken, Horse, Human, Mouse, Pig, Rat
Spin vial briefly before opening. Reconstitute with 100 µL sterile-filtered, ultrapure water to achieve a 1 mg/mL concentration. Centrifuge to remove any insoluble material. After reconstitution of lyophilized antibody, divide into single use aliquots and store at -20-80°C for a higher stability. Avoid freeze-thaw cycles.
Lyophilized
Protein G purified
Lyophilized from PBS buffer pH 7.2-7.6 with 0.1% trehalose, and sodium azide
WB: 1:1000-1:5000
IHC: 1:500-1:3000
ICC: 1:500-1:3000
IHC: 1:500-1:3000
ICC: 1:500-1:3000
Unconjugated
The specificity of this antibody has been confirmed by WB. This antibody detects ~14-15 kDa alpha synuclein protein. The epitope for 3H9 is in the region 61-95 which correspond to the Non-Amyloid beta Component of Alzheimer's disease amyloid (NAC) region. 3H9 will also bind human alpha-synuclein containing the A30P and A53T mutations. Human, horse, cow, pig, chicken, rat, mouse. Predicted to react with other mammalian tissue because of highly conserved nature of the protein.
For research use only.
United States
12 months after date of receipt (unopened vial).
Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
25°C (ambient)